Hisato Takagi, Takuya Umemoto. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AtorvastatinContrast Media/adverse effectsHeptanoic Acids/administration & dosageHumansKidney Diseases/chemically inducedKidney Diseases/prevention & controlPyrroles/administration & dosageRandomized Controlled Trials as Topic/methodsTreatment Outcome
Substances: See more » Contrast MediaHeptanoic AcidsPyrrolesAtorvastatin
Year: 2011 PMID: 21924779 DOI: 10.1016/j.ijcard.2011.08.047
Source DB: PubMed Journal: Int J Cardiol ISSN: 0167-5273 Impact factor: 4.164